2011
DOI: 10.1007/174_2011_313
|View full text |Cite
|
Sign up to set email alerts
|

Advances in Supportive and Palliative Care for Lung Cancer Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 122 publications
0
1
0
Order By: Relevance
“…Nd:YAG LA has been used as palliative treatments for several other cancers, e.g., colorectal [ 47 , 48 ], pancreas neuroendocrine tumors [ 39 ], lung [ 35 , 49 ], glioblastoma [ 36 ], osteoid osteoma [ 37 ], renal [ 38 ], ureteral tumors [ 50 ], and breast cancer [ 51 ]. These uses have generally been delivered at power settings of 5 W and a few minutes of application, or at high (50 W) power with short pulses of 1–3 s.…”
Section: Lasers In Surgerymentioning
confidence: 99%
“…Nd:YAG LA has been used as palliative treatments for several other cancers, e.g., colorectal [ 47 , 48 ], pancreas neuroendocrine tumors [ 39 ], lung [ 35 , 49 ], glioblastoma [ 36 ], osteoid osteoma [ 37 ], renal [ 38 ], ureteral tumors [ 50 ], and breast cancer [ 51 ]. These uses have generally been delivered at power settings of 5 W and a few minutes of application, or at high (50 W) power with short pulses of 1–3 s.…”
Section: Lasers In Surgerymentioning
confidence: 99%